Amicus Therapeutics Presents Positive Preclinical Pompe Disease Gene Therapy Data at the American Society of Gene & Cell Therapy (ASGCT) 22nd Annual Meeting - Yahoo Finance
Amicus Therapeutics Presents Positive Preclinical Pompe Disease Gene Therapy Data at the American Society of Gene & Cell Therapy (ASGCT) 22nd Annual Meeting Yahoo Finance
Amicus Therapeutics (FOLD) today announced initial preclinical data from its investigational adeno-associated viral (AAV) gene therapy program for Pompe ...
Comments
Post a Comment